[1]
Pinto, M.E. and Manrique, H.A. 2010. Withdrawal of sibutramine for cardiovascular disease risk. Revista Peruana de Medicina Experimental y Salud Pública. 27, 3 (Sep. 2010). DOI:https://doi.org/10.17843/rpmesp.2010.273.1517.